Sign In
Buy FREQ
$0.300
+0 (+0%)
At Close: Feb 02, 2024
Frequency Exchange Corp. Appoints Gail Edgell To Advisory Board
08:30am, Wednesday, 17'th Dec 2025
Vancouver, British Columbia – December 17, 2025 – TheNewswire - Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) (“Frequency Exchange” or the “Company”) is pleased to announce the appoin
Frequency Exchange Appoints Michael MOE To Advisory Board
08:30am, Friday, 12'th Dec 2025
Vancouver, British Columbia – December 15, 2025 – TheNewswire – Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) (“Frequency Exchange” or the “Company”) is pleased to announce the appo
NIKKI's Efficacy in Overcoming Lyme Disease to be Presented at 2024 Leap into Health Conference
08:00am, Friday, 13'th Dec 2024
VANCOUVER, BC / ACCESSWIRE / December 13, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ)(OTC PINK:FRECF), a company focused on the global commercialization of its
UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
03:31pm, Friday, 03'rd Nov 2023
CAMBRIDGE, Mass. and LEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company with a mission to discover, develop and commercialize a new
Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
12:19pm, Friday, 03'rd Nov 2023
CAMBRIDGE, Mass. and LEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company with a mission to discover, develop and commercialize a new
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Frequency Th
Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results
04:01pm, Thursday, 10'th Aug 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023. In July, the Company a
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Frequency Th
Frequency (FREQ) Up 77% on Merger Deal With Korro Bio
01:32pm, Monday, 17'th Jul 2023
Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will apply to trade on the NASDAQ under the ticker symbo
FREQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Frequency Therapeutics, Inc. Is Fair to Shareholders
10:00am, Friday, 14'th Jul 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Frequency Therapeutics, Inc. (NASDAQ: FREQ) and Korro Bio, Inc. is fair to Frequency sh
Why Is Frequency Therapeutics (FREQ) Stock Up 44% Today?
08:00am, Friday, 14'th Jul 2023
Frequency Therapeutics (NASDAQ: FREQ ) stock is rocketing higher on Friday following news that it will combine with Korro Bio . This merger plan is designed to bring Korro Bio public and will focus o
Korro Bio and Frequency Therapeutics Announce Merger Agreement
06:30am, Friday, 14'th Jul 2023
CAMBRIDGE & LEXINGTON, Mass.--(BUSINESS WIRE)--Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, and Frequency Therapeutics, Inc. (Nas
Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results
04:01pm, Friday, 12'th May 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore fu
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
07:30am, Friday, 10'th Mar 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore fu
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
07:30am, Monday, 27'th Feb 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore fu
